Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Yusen Zhou, Yang Yang, Jingwei Huang, et al.
Viruses (2019) Vol. 11, Iss. 1, pp. 60-60
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development
Jubeda Begum, Nasir Akbar Mir, Kapil Dev, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 3, pp. 1111-1124
Open Access | Times Cited: 43
SARS-CoV-2 Vaccine Development: An Overview and Perspectives
Yi Liu, Kai Wang, Tarik F. Massoud, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 5, pp. 844-858
Open Access | Times Cited: 43
Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy
Hongjing Gu, Qi Chen, Guan Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 40
Ribosome Display Technology: Applications in Disease Diagnosis and Control
Adinarayana Kunamneni, Christian Ogaugwu, Steven B. Bradfute, et al.
Antibodies (2020) Vol. 9, Iss. 3, pp. 28-28
Open Access | Times Cited: 39
Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study
Mai Aly, Taghreed S. Meshref, Marwa Ahmed Abdelhameid, et al.
Journal of Blood Medicine (2021) Vol. Volume 12, pp. 505-515
Open Access | Times Cited: 36
MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, et al.
Annals of Clinical Microbiology and Antimicrobials (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 35
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study
Souvik Banerjee, Shalini Yadav, Sourav Banerjee, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 11, pp. 5469-5483
Closed Access | Times Cited: 34
Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
Ge Li, Aiping Wang, Yumei Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 32
Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 13
Nanobodies: Prospects of Expanding the Gamut of Neutralizing Antibodies Against the Novel Coronavirus, SARS-CoV-2
Rocktotpal Konwarh
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 37
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV
Nisreen M.A. Okba, Ivy Widjaja, Brenda van Dieren, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 1080-1091
Open Access | Times Cited: 33
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Exploring genetic landscape of low-density polyethylene degradation for sustainable troubleshooting of plastic pollution at landfills
Roshani Mishra, Priyank Chavda, Rakesh Kumar, et al.
The Science of The Total Environment (2023) Vol. 912, pp. 168882-168882
Closed Access | Times Cited: 11
MERS Coronavirus: An Emerging Zoonotic Virus
Fang Li, Lanying Du
Viruses (2019) Vol. 11, Iss. 7, pp. 663-663
Open Access | Times Cited: 33
CoV-AbDab: the Coronavirus Antibody Database
Matthew I. J. Raybould, Aleksandr Kovaltsuk, Claire Marks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 28
Coronaviruses pandemics: Can neutralizing antibodies help?
Phuoc Bao Viet Tong, Liyun Lin, Tuan Hiep Tran
Life Sciences (2020) Vol. 255, pp. 117836-117836
Open Access | Times Cited: 28
Advances in mRNA and other vaccines against MERS-CoV
Wanbo Tai, Xiujuan Zhang, Yang Yang, et al.
Translational research (2021) Vol. 242, pp. 20-37
Open Access | Times Cited: 23
MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
Wanbo Tai, Jian Zheng, Xiujuan Zhang, et al.
Virus Research (2023) Vol. 334, pp. 199156-199156
Open Access | Times Cited: 9
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling
Hyun Lee, Jinhong Ren, Russell P. Pesavento, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 10, pp. 1981-1989
Open Access | Times Cited: 28
Nanoparticles‐assisted delivery of antiviral‐siRNA as inhalable treatment for human respiratory viruses: A candidate approach against SARS‐COV‐2
Ata Ullah, Javaria Qazi, Lutfur Rahman, et al.
Nano Select (2020) Vol. 1, Iss. 6, pp. 612-621
Open Access | Times Cited: 25
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview
Jitendra Singh Rathore, Chaitali Ghosh
Pathogens and Disease (2020) Vol. 78, Iss. 6
Open Access | Times Cited: 23
Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody
Cong Wang, Ze Wu, Bochao Liu, et al.
Biosensors and Bioelectronics (2021) Vol. 192, pp. 113550-113550
Open Access | Times Cited: 22
SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants
Almu’atasim Khamees, Jamal Bani-Issa, Mazhar Salim Al Zoubi, et al.
Pathogens (2022) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 14
Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19
Dhanusha A. Nalawansha, Kusal T. G. Samarasinghe
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 5, pp. 790-800
Open Access | Times Cited: 23
Molecular Pathogenesis of Middle East Respiratory Syndrome (MERS) Coronavirus
Arinjay Banerjee, Kaushal Baid, Karen L. Mossman
Current Clinical Microbiology Reports (2019) Vol. 6, Iss. 3, pp. 139-147
Open Access | Times Cited: 22

Scroll to top